Browsing by Author Permsuwan U.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
2012Anticoagulation control of pharmacist-managed collaborative care versus usual care in ThailandSaokaew S.; Sapoo U.; Nathisuwan S.; Chaiyakunapruk N.; Permsuwan U.
2012Anticoagulation control of pharmacist-managed collaborative care versus usual care in ThailandSaokaew S.; Sapoo U.; Nathisuwan S.; Chaiyakunapruk N.; Permsuwan U.
2012Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand.Saokaew S.; Sapoo U.; Nathisuwan S.; Chaiyakunapruk N.; Permsuwan U.
24-Dec-2014Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) databaseSuwankesawong W.; Saokaew S.; Saokaew S.; Saokaew S.; Permsuwan U.; Chaiyakunapruk N.; Chaiyakunapruk N.; Chaiyakunapruk N.; Chaiyakunapruk N.
2010Confirmatory factor analysis of an instrument to assess quality in pharmacy service of highly-active antiretroviral therapy programChaitha W.; Viboonsunti C.; Permsuwan U.; Awipan R.; Karnjanarat P.
2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerThongprasert S.; Permsuwan U.; Ruengorn C.; Charoentum C.; Chewaskulyong B.
2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerThongprasert S.; Permsuwan U.; Ruengorn C.; Charoentum C.; Chewaskulyong B.
21-Sep-2016Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in ThailandPermsuwan U.; Dilokthornsaku P.; Saokaew S.; Thavorn K.; Chaiyakunapruk N.
2Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in ThailandPermsuwan U.; Dilokthornsakul P.; Thavorn K.; Saokaew S.; Chaiyakunapruk N.
9Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspectivePermsuwan U.; Thavorn K.; Dilokthornsakul P.; Saokaew S.; Chaiyakunapruk N.
2013Cost-effectiveness of pharmacist-participated warfarin therapy management in ThailandSaokaew S.; Permsuwan U.; Chaiyakunapruk N.; Nathisuwan S.; Sukonthasarn A.; Jeanpeerapong N.
2013Cost-effectiveness of pharmacist-participated warfarin therapy management in ThailandSaokaew S.; Permsuwan U.; Chaiyakunapruk N.; Nathisuwan S.; Sukonthasarn A.; Jeanpeerapong N.
2012Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspectiveThongprasert S.; Tinmanee S.; Permsuwan U.
5Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in ThailandThongprasert S.; Permsuwan U.
2010Effectiveness of pharmacist-participated warfarin therapy management: A systematic review and meta-analysisSaokaew S.; Permsuwan U.; Chaiyakunapruk N.; Nathisuwan S.; Sukonthasarn A.
2010Effectiveness of pharmacist-participated warfarin therapy management: A systematic review and meta-analysisSaokaew S.; Permsuwan U.; Chaiyakunapruk N.; Nathisuwan S.; Sukonthasarn A.
-Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysisYoodee J.; Permsuwan U.; Nimworapan M.
1-Jan-2016Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in ThailandPermsuwan U.; Chaiyakunapruk N.; Dilokthornsakul P.; Thavorn K.; Saokaew S.
2011Safety of herbal products in Thailand: An analysis of reports in the thai health product vigilance center database from 2000 to 2008Saokaew S.; Suwankesawong W.; Permsuwan U.; Chaiyakunapruk N.